Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 220991-32-2
2. Onsior
3. Robenacoxib [inn]
4. 2-(5-ethyl-2-((2,3,5,6-tetrafluorophenyl)amino)phenyl)acetic Acid
5. 2-[5-ethyl-2-(2,3,5,6-tetrafluoroanilino)phenyl]acetic Acid
6. Chebi:76269
7. Cgs 34975
8. Z588009c7c
9. (5-ethyl-2-((2,3,5,6-tetrafluorophenyl)amino)phenyl)acetic Acid
10. Robenacoxibum
11. {5-ethyl-2-[(2,3,5,6-tetrafluorophenyl)amino]phenyl}acetic Acid
12. Robenacoxib [mi]
13. Schembl6036596
14. Zinc7562
15. Chembl2107774
16. Robenacoxib [green Book]
17. Unii-z588009c7c
18. Dtxsid90176607
19. Bcp23758
20. Mfcd27966869
21. Db11455
22. Ncgc00532515-01
23. Robenacoxib [ema Epar Veterinary]
24. Cs-0065148
25. Ft-0674451
26. C20708
27. A902615
28. J-014494
29. Q7341121
30. 5-ethyl-2-(2',3',5',6'-tetrafluoroanilino)phenylacetic Acid
31. 5-ethyl-2-(2', 3', 5', 6'-tetrafluoroanilino)phenylacetic Acid
32. 5-ethyl-2-(2', 3',5',6'-tetrafluoroanilino)phenylacetic Acid
33. 5-ethyl-2-(2',3',5', 6'-tetrafluoroanilino)phenylacetic Acid
34. 5-ethyl-2-(2',3',5',6'-tetrafluoroanilino) Phenylacetic Acid
Molecular Weight | 327.27 g/mol |
---|---|
Molecular Formula | C16H13F4NO2 |
XLogP3 | 4.1 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 5 |
Exact Mass | 327.08824131 g/mol |
Monoisotopic Mass | 327.08824131 g/mol |
Topological Polar Surface Area | 49.3 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 398 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Cats (tablets):
For the treatmentRelief of pain and inflammation associated with acute andor chronic musculo-skeletal disorders.
For the reduction of moderate pain and inflammation associated with orthopaedic surgery.
Dogs (tablets):
For the Ttreatment of pain and inflammation associated with chronic osteoarthritis .
For the treatment of pain and inflammation associated with soft tissue surgery.
Cats and dogs (solution for injection):
For the Ttreatment of pain and inflammation associated with orthopaedic or soft tissue surgery.
QM01AH91
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
NDC Package Code : 86055-0015
Start Marketing Date : 2019-06-26
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
VMF Number : 6334
Submission : 2019-09-25
Status : Active
Type : II
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?